Posts

After Promising Review Of Deadly Abortion Pill, FDA Greenlights A Copycat Version

/0 Comments/in , /by

Twenty-five years after the U.S. Food and Drug Administration bypassed safety concerns to approve what has become the most popular abortion method on the market, the agency greenlit a generic version of mifepristone manufactured by a company committed to “normalizing” abortion for all.

The news broke mere weeks after the FDA formally committed to re-examining the factors that could prompt it to limit, if not revoke, permission for mifepristone’s prevalence in the U.S.

Health and Human Services Secretary Robert F. Kennedy Jr. confirmed to the Senate Finance Committee on Sept. 4 that the FDA was evaluating “new data” on mifepristone.

“We know that during the Biden administration, they actually twisted the data to bury one of the safety signals with a very high safety signal, around 11 percent,” Kennedy added.

In a joint letter to 22 Republican attorneys general on Sept. 19, Kennedy and FDA Commissioner Marty Makary both reiterated that the federal regulators planned their “own review of the evidence, including real-world outcomes and evidence, relating to the safety and efficacy.” (Read more from “After Promising Review Of Deadly Abortion Pill, FDA Greenlights A Copycat Version” HERE)

Propublica Awarded Pulitzer After Blaming Georgia Woman’s Abortion Pill Death on Pro-Life Laws

/0 Comments/in , /by

If Americans needed further proof that the Pulitzer Prize has become nothing more than a glorified gold sticker given to the media’s biggest left-wing propagandists, the award’s 2025 winners are sure to convince them.

Included in the batch of this year’s winners is none other than ProPublica, a left-wing outlet reportedly bankrolled by leftist mega-donors and notorious for running interference for the Democrat Party and its allies. Several of the outlet’s writers won a Pulitzer last year for their dishonest smear campaign against Supreme Court Justice Clarence Thomas.

The Pulitzer given to ProPublica this year is equally, if not more, reprehensible.

According to the Associated Press, ProPublica’s Kavitha Surana, Lizzie Presser, Cassandra Jaramillo, and Stacy Kranitz were awarded for what the AP characterizes as “reporting on pregnant women who died after doctors delayed urgent care in states with strict abortion laws.” What the Associated Press declines to mention, however, is that ProPublica’s “reporting” was left-wing propaganda designed to vilify life-saving pro-life laws in states across the country.

As The Federalist’s Jordan Boyd reported, ProPublica ran a story by Surana less than two months before the 2024 general election of a Georgia woman named Amber Thurman and her unborn twins. While Thurman “died in 2022 after … suffer[ing] untreated complications from the dangerous drug regimen responsible for more than half of the nation’s abortions,” ProPublica “blam[ed] confusion about Georgia’s lifesaving abortion limits for [her] death.” (Read more from “Propublica Awarded Pulitzer After Blaming Georgia Woman’s Abortion Pill Death on Pro-Life Laws” HERE)

Study: Rate Of Serious Or Life-Threatening Complications After Abortion Pill Is 22 Times Higher Than FDA Claims

/0 Comments/in , /by

Abortion advocates, their allies in the corporate media, and even the U.S. Food and Drug Administration insist the pill responsible for more than half of the nation’s abortions is “safe and effective.” A new, wide-ranging analysis of insurance claims regarding the abortion drug regimen, however, found that the rate of life-threatening complications due to mifepristone is at least 22 times higher than what the FDA and Danco Laboratories, manufacturer of mifepristone pill Mifeprex, suggest.

In the “largest known study of the abortion pill,” Ethics and Public Policy Center President Ryan Anderson and Director of Data Analysis Jamie Bryan Hall used purchased Medicaid, TRICARE, Medicare, Department of Veterans Affairs, and private medical insurance claim data to determine that 865,727 mifepristone abortion prescriptions for 692,873 women were handed out between 2017 and 2023.

Approximately 10.9 percent of those claims, or 94,605 chemical abortions, involved potentially life-threatening “serious adverse events” such as emergency room visits, hemorrhage, sepsis, infection, and/or follow-up surgeries for the women who had downed the abortion drug within the last 45 days.

That rate, which researchers adjusted to reflect “that some women suffer from adverse events in multiple categories,” is 22 times the FDA’s <0.5 percent estimation printed on the Mifeprex label. The researchers also suggest that the 45-day timeframe they used is “conservative, as some adverse events may present later (and studies relied on by the FDA used a timeframe as long as 72 days).” “This study is the statistical equivalent of a category 5 hurricane hitting the prevailing narrative of the abortion industry,” Anderson said in a statement to The Federalist. “It reveals, based on real-world data, the shocking number of women who suffer serious medical consequences because of the abortion pill.” (Read more from "Study: Rate Of Serious Or Life-Threatening Complications After Abortion Pill Is 22 Times Higher Than FDA Claims" HERE)

Study on Dangers of Abortion Pill Retracted Ahead of Supreme Court Hearing

/2 Comments/in , /by

A major academic publisher has retracted three articles by a leading pro-life research group, including a study raising medical concerns about the abortion pill ahead of a Supreme Court hearing on the drug’s federal approval.

Sage Journals removed three articles published in 2019, 2021 and 2022 by the pro-life Charlotte Lozier Institute, citing concerns about conflicts of interest and “lack of scientific rigor,” which prompted the institute to accuse Sage of an “unprovoked and partisan assault” on its research.

The studies were pulled Monday, a week after the Supreme Court scheduled oral arguments for March 26 in Alliance for Hippocratic Medicine v. FDA, a case challenging the Food and Drug Administration’s 2000 approval of mifepristone for pregnancy termination.

In April, U.S. District Judge Matthew Kacsmaryk placed a temporary hold on the approval, citing the institute’s 2021 study of Medicaid claims data, which found the rate of abortion-related emergency-room visits by women who had taken the abortion pill within the previous 30 days jumped by 500% from 2002 to 2015.

“Sage is targeting us because we have been successful in calling attention to some of the dangers that are associated with abortion, and specifically chemical abortion,” said James Studnicki, Lozier vice president for data analytics and the lead author on all three studies. (Read more from “Study on Dangers of Abortion Pill Retracted Ahead of Supreme Court Hearing” HERE)

💪 Dependence on You:

We’ve weathered storms, but today, we rely entirely on your generosity to keep our platform alive. Your support is not just a donation; it’s a partnership in upholding the values that define us. Together, let’s defy challenges and ensure Restoring Liberty thrives for another two decades.

🌐 How You Can Make a Difference:

Your contribution is a vital lifeline for us. By donating HERE, you become an integral part of our mission. Every dollar is an investment in preserving a powerful conservative voice that resonates across the nation.

🙏 Join Us in Shaping the Future:

Help us overcome the financial hurdles that come with independence. Your donation paves the way for continued growth, impact, and influence. Together, let’s empower Restoring Liberty to shape the future of conservative values.

🔗 Donate HERE and be a Guardian of Liberty!

Thank you for being the backbone of Restoring Liberty. With your support, we’ll stand strong for another two decades and beyond!